e2v CMOS imaging sensors offer >80% quantum efficiency

e2v Ruby CMOS imaging sensors

Ruby CMOS imaging sensors offer a pixel size of 5.3 μm, quantum efficiency >80%, and performance in the near-infrared spectrum (>50% at 850 nm). Ruby EV76C660 combines high sensitivity and low noise for night vision and outdoor cameras in security applications, while Ruby EV76C661 combines extended wavelength sensitivity and global shutter efficiency for machine vision cameras and intelligent traffic systems.
e2v
Chelmsford, England

www.e2v.com

More Products

-----

PRESS RELEASE

e2v launches 1.3MP Ruby CMOS imaging sensors

e2v, the leading global provider of high performance imaging solutions, has launched two new devices from the e2v Ruby family of CMOS imaging sensors, the EV76C660 and EV76C661.  These sensors have sensitivity performance beyond that previously considered possible on traditional front side illuminated sensors, with an extended wavelength range.

The new Ruby sensors are a derivative of e2v’s widely acclaimed Sapphire CMOS sensors; offering a pixel size of 5.3μm, Quantum Efficiency (QE) of over 80% and excellent sensitivity and performance in the near-infrared spectrum (>50% at 850nm).  Both Ruby imaging sensors significantly reduce system illumination costs, or enable very low-light imaging in outdoor camera applications. The same package, pin-out and software interface as e2v’s Sapphire family gives customers access to a range of differentiated industrial camera products from a single hardware and software development.

The Ruby EV76C660 is optimised for rolling shutter operation and combines very high sensitivity and low noise. It is the perfect device for night vision and outdoor cameras, for example in high-end security applications.  The Ruby EV76C661 combines the family’s extended wavelength sensitivity with best-in-class global shutter efficiency. It is perfect for applications that need to capture fast moving objects, for example in machine vision cameras or intelligent traffic systems.

Frederic Devriere, marketing manager at e2v said “The low power consumption of these new Ruby sensors makes them ideal for hand-held devices or personal equipment, presenting ground-breaking performance.  Key customers that have sampled the new devices have already given positive feedback, finding them easy-to-use and integrate.  Overall the enhanced sensitivity of these sensors, combined with their extended wavelength range means they represent the best price/performance ratio you can find in the market”.

About e2v

e2v is a leading global provider of specialist technology for high performance systems and equipment; delivering solutions, sub-systems and components for specialist applications within medical & science, aerospace & defence, and commercial & industrial markets. e2v has its headquarters in the UK, employs approximately 1500 people, has design and production facilities across Europe and North America, and has a global network of sales and technical support offices. For the year ended 31 March 2011, e2v reported sales of £229m and is listed on the London Stock Exchange. For more information visit e2v.com.

-----

Follow us on Twitter

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to Laser Focus World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Third FDA-approved study supports additional potential use of laser ablation technology

The FDA has approved an additional Investigational Device Exemption (IDE) to evaluate the NeuroBlate laser ablation system.

Contract to provide U.S. Armed Forces access to laser procedure for gum tissue regeneration

The U.S. Armed Forces will have access to a laser procedure for fully regenerating gum tissues lost to disease.

Avinger signs agreement with HealthTrust for OCT image-guided atherectomy system

HealthTrust will acquire Avinger's Pantheris OCT image-guided atherectomy system that recently received FDA approval.

SalutarisMD to introduce minimally invasive ophthalmic device for wet AMD therapy

SalutarisMD has developed an investigational ophthalmic treatment for wet age-related macular degeneration (AMD).

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS